You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 248 No. 16, October 22, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

RBC Zinc Protoporphyrin to Screen Blood Donors for Iron Deficiency Anemia

Ron B. Schifman, MD; Shirley L. Rivers, MD; Paul R. Finley, MD; Cole Thies, MSPH

JAMA. 1982;248(16):2012-2015.


Abstract

We evaluated a rapid RBC zinc protoporphyrin (ZP) test in 1,147 male and 615 female blood donors to study its value in screening for evolving iron deficiency anemia. Fifteen men (1.8%) and 32 women (7.9%) who returned to donate were found to be anemic. A matched sample analysis between anemic and nonanemic donors demonstrated significant differences in serum ferritin levels, percent iron saturation, and the RBC ZP level from samples collected during the initial evaluation. Red cell ZP correlated well with the natural logarithm of serum ferritin in both men and women who later became anemic. The predictive value of RBC ZP levels compared favorably with that of the serum ferritin level. We also observed a strong association between the yearly donation frequency and RBC ZP concentration. These findings indicate that predonation RBC ZP testing may be useful in screening for iron depletion and potential risk of anemia in blood donors.

(JAMA 1982;248:2012-2015)



Author Affiliations

From the Departments of Clinical Pathology (Drs Schifman and Finley) and Computer Systems and Biostatistics (Mr Thies), University of Arizona Health Sciences Center, and the Southern Arizona Red Cross Blood Center (Dr Rivers), Tucson. Presented in part at the 34th annual meeting of the American Association for Blood Banks, Chicago, Nov 4, 1981.


Footnotes

Reprint requests to Department of Clinical Pathology, Arizona Health Sciences Center, Tucson, AZ 85724 (Dr Schifman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Screening Healthy Infants for Iron Deficiency Using Reticulocyte Hemoglobin Content
Ullrich et al.
JAMA 2005;294:924-930.
ABSTRACT | FULL TEXT  

Zinc Protoporphyrin: A Metabolite with a Mission
Labbe et al.
Clin. Chem. 1999;45:2060-2072.
ABSTRACT | FULL TEXT  

Zinc protoporphyrin as screening test in female blood donors
Harthoorn-Lasthuizen et al.
Clin. Chem. 1998;44:800-804.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.